Today’s presentation at CTAD, a leading international Alzheimer's conference, expands research supporting the value of ultra-low-field MRI in monitoring amyloid-related imaging abnormalities (ARIA).

A University of New Mexico scientist is revealing what might be one of the most overlooked causes of dementia — damage in the brain’s tiny blood vessels. Dr. Elaine Bearer has created a new way to ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sinaptica Therapeutics, Inc., a clinical-stage company leading the development of a new class of personalized neuromodulation therapeutics to treat Alzheimer’s and ...

The Mizzou Point-of-Care Assessment System, or MPASS, tests a person's motor ability through three activities: standing still, walking, and standing up from a bench, all while counting backwards in ...

Hyperfine Swoop® AI-Powered Portable MRI System Demonstrates 100% Sensitivity for ARIA-E Detection in New Data Presented at the 2025 Alzheimer’s Association International Conference Interim results ...